Analysis of drug combinations: current methodological landscape

Julie Foucquier1, Mickael Guedj1

  • 1Department of Bioinformatics and Biostatistics, Pharnext Issy-Les-Moulineaux, France.

Insights

Combination therapies offer improved efficacy and reduced toxicity, making them crucial for treating diseases. This review clarifies methods for studying drug combinations to ensure rigorous and effective therapeutic development.

Area of Science:

  • Pharmacology
  • Biostatistics
  • Drug Development

Background:

  • Combination therapies are increasingly vital for treating complex diseases, offering enhanced efficacy and reduced toxicity.
  • Despite their advantages, challenges in studying drug combination effects persist, necessitating methodological clarity.

Purpose of the Study:

  • To provide an overview of the current methodological landscape for studying drug combination effects.
  • To elucidate essential mathematical and pharmacological concepts underpinning common combination study approaches.
  • To identify and discuss key methodological issues in developing new combination therapies.

Main Methods:

  • Review and synthesis of existing literature on combination therapy study methodologies.
  • Categorization of approaches into effect-based and dose-effect-based methods.
  • Discussion of practical advantages, limitations, and common challenges.

Main Results:

  • Established foundational concepts for understanding combination effect analyses.
  • Detailed comparison of effect-based and dose-effect-based approaches.
  • Identified six critical methodological issues encountered in combination therapy development.

Conclusions:

  • A standardized, universally applicable methodology for all biomedical situations is currently absent.
  • Rigorous and collective application of reviewed concepts and methods is essential for advancing drug combination studies.
  • Improved methodological understanding can accelerate the development of superior combination therapies.

Related Concept Videos

Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
1.3K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
932
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
7.6K
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
673
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
2.1K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
405